Radiculopathy clinical trial scenario

“Radiculopathy Global Clinical Trials Review, H1, 2013" provides data on the Radiculopathy clinical trial scenario. This provides elemental information and data relating to the clinical trials on Radiculopathy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Radiculopathy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by  team of industry experts.

To Know More :   Radiculopathy  Global  Clinical  Trials  Review

Opportunities in US Blood Banking Market

Major issues pertaining to the US blood banking practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Specifically, the study explores the impact of anticipated changes in government regulations, trends in complicated surgeries, birth rate and other key issues.Ten-year volume and sales forecasts for 40 blood typing, grouping and infectious disease screening tests, including NAT procedures performed in US community and regional blood centers, hospitals, commercial laboratories, and plasma fractionation facilities.Annual placements and installed base estimates for major automated and semiautomated analyzers.Review of current instrumentation technologies, and a feature comparison of over 20 analyzers.Ten-year reagent and instrument sales forecasts.Sales and market shares of leading reagent and instrument suppliers.Review of current and emerging technologies, and their potential market applications.
Product development opportunities for instruments ,consumables, and auxiliary products.Profiles of major current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Business opportunities and strategic recommendations for suppliers.
To Know More : Blood Banking Market

The Global Market for Pain Management Drugs and Devices

The Global Market for Pain Management Drugs and Devices, provides an overview of products included in this market, and detailed analyses of markets and competitive environments. The study includes information about significant products, players, issues and trends, regulatory issues, and other information affecting the pain management industry.This study will provide the reader with the knowledge to adequately view and assess pain management and the problems that the healthcare industry faces as well as provide insights into the market potentials. This covers a wide variety of treatments and products that many people worldwide rely on.This BCC Research report is designed to be a helpful business tool that will provide a thorough evaluation of the markets for pain management. The geographical scope of this study is global with a U.S. emphasis. This study will address acute versus chronic pain, treatments, and regulatory issues facing healthcare workers. Also provided is detailed information based on product categories, use of products, forecasts, and competitive analyses.
To Know More :  Pain Management Drugs and Devices Market

In-depth analysis of the global remote patient monitoring market

“Remote Patient Monitoring Market to 2019 - Potential to Reduce Healthcare Cost Burden and Improve Quality of Care to Drive Future Growth” looks at the market, competitive landscape, and trends for the two remote patient monitoring market segments: implantable remote patient monitoring and external remote patient monitoring. The report provides comprehensive information on the key trends affecting these segments, and key analytical content on the market dynamics. The report also reviews the competitive landscape and gives a detailed analysis of each segment’s pipeline products, as well as details of important M&A deals. It is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Research’s team of industry experts.
To Know More : Remote Patient Monitoring Market

Healthcare Building Construction in Portugal

'Healthcare Building Construction in Portugal to 2017: Market Databook' contains detailed historic and forecast market value data for the healthcare buildings construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). The databook provides historical and forecast valuations of the industry using the construction output and value-add methods.This report is the result of extensive market research covering the healthcare buildings construction industry in Portugal. It contains detailed historic and forecast market value data for the healthcare buildings construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). 'Healthcare Building Construction in Portugal to 2017: Market Databook' provides a top-level overview and detailed insight into the operating environment of the healthcare buildings construction industry in Portugal. It is an essential tool for companies active across the Portuguese construction value chain and for new players considering to enter the market.
To Know More : Healthcare Building Construction in Portugal

Healthcare Insurance in Estonia

'Healthcare Insurance in Estonia to 2017: Market Databook' contains detailed historic and forecast data covering healthcare insurance in the personal accident and health insurance industry in Estonia. This databook provides data on gross written premiums, earned premiums, number of active policies, number of schemes offered, penetration percentage, gross claims, paid claims, change in outstanding reserves, incurred loss and loss ratio percentage.

To Know More : Healthcare Insurance in Estonia

Analgesics in Australia

Arthritis was a key driver of sales within analgesics in 2012. A report by Access Economics found that 3.85 million Australians suffer with a form of arthritis, with the figure expected to double by 2050. With Australians worried about developing arthritis more than any other disease, brand operators have focused on developing more effective products for the relief of arthritic pain.
To Know More : Analgesics in Australia